Clinical Trial Update: CRF2 Agonist for the Treatment of Worsening Heart Failure [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update for a CRF2 agonist aimed at treating worsening heart failure, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• CRF2 agonist

Snippet

Sponsor: Corteria Pharmaceuticals | Conditions: Worsening Heart Failure | Phase 2 | Status: RECRUITING